Mesh Fixation and Closure of Peritoneum Following Laparoscopic Hernia Repair Using N-butyl Cyanoacrylate
NCT ID: NCT02457728
Last Updated: 2015-12-11
Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
34 participants
INTERVENTIONAL
2015-01-31
2015-08-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In addition, closure of peritoneum should be accomplished using this device.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Inguinal herniation
In patients with bilateral herniations it should be explored if one glue device (LiquiBandFix8) for mesh fixation and closure of peritoneum is sufficient.
LiquiBandFix8
Using LiquiBandFix8 for mesh fixation and peritoneal closure following TAPP repair.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
LiquiBandFix8
Using LiquiBandFix8 for mesh fixation and peritoneal closure following TAPP repair.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* femoral hernia
Exclusion Criteria
* not able to understand patient information
18 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
St John of God Hospital, Vienna
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Bernhard Dauser, MD
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernhard DAUSER, MD
Role: PRINCIPAL_INVESTIGATOR
St John of God Hospital, Vienna
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
St John of God Hospital
Graz, Styria, Austria
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
StJohn
Identifier Type: -
Identifier Source: org_study_id